Molecule
Donor human stool spores (ethanol treated) is a prescription medicine. It is available as capsules for oral use. MedsAcross supplies Donor human stool spores (ethanol treated) for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
VOWST is indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI). Limitation of Use: VOWST is not indicated for treatment of CDI.
Source: US FDA prescribing information
The mechanism of action of VOWST has not been established.
Source: US FDA prescribing information
For oral administration only. Prior to taking the first dose: Complete antibacterial treatment for rCDI 2 to 4 days before initiating treatment with VOWST. Drink 296 mL (10 oz) of magnesium citrate on the day before and at least 8 hours prior to taking the first dose of VOWST. In clinical studies, participants with impaired kidney function received polyethylene glycol electrolyte solution (250 mL GoLYTELY, not approved for this use). The dosage of VOWST is 4 capsules taken orally once daily for 3 consecutive days. Take each dose (4 capsules) on an empty stomach prior to the first meal of the day.
Source: US FDA prescribing information
None. None.
Source: US FDA prescribing information
Transmissible infectious agents Because VOWST is manufactured from human fecal matter, it may carry a risk of transmitting infectious agents. Any infection suspected by a healthcare provider possibly to have been transmitted by this product should be reported by the healthcare provider to Aimmune Therapeutics, Inc. at 1-833-246-2566.
Source: US FDA prescribing information
The most common adverse reactions (reported in ≥5% of participants) were abdominal distension (31.1%), fatigue (22.2%), constipation (14.4%), chills (11.1%), and diarrhea (10.0%). Most common adverse reactions (reported in ≥5% of participants) were abdominal distension (31.1%), fatigue (22.2%), constipation (14.4%), chills (11.1%) and diarrhea (10.0%).
Source: US FDA prescribing information
VOWST contains bacterial spores, therefore, antibacterials should not be administered concurrently with VOWST. Antibacterials should not be administered concurrently with VOWST.
Source: US FDA prescribing information
Store VOWST in the original packaging at 2° to 25°C (36° to 77°F). Do not store in the freezer.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
1 presentations of Donor human stool spores (ethanol treated), sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Vowst 30000000 CFU capsuleOral | Aimmune Therapeutics | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Not recorded | — |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 1 presentations of Donor human stool spores (ethanol treated) and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Donor human stool spores (ethanol treated), including Vowst.
No listed presentation of Donor human stool spores (ethanol treated) is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.